| # | Country | Total Patents | |
|---|---|---|---|
| #1 | WIPO (World Intellectual Property Organization) | 4 | |
| #2 | China | 3 | |
| #3 | Australia | 2 | |
| #4 | Canada | 2 | |
| #5 | EPO (European Patent Office) | 1 | |
| #6 | Republic of Korea | 1 | |
| #7 | United States | 1 |
| # | Industry | |
|---|---|---|
| #1 | Biotechnology | |
| #2 | Pharmaceuticals |
| # | Technology | |
|---|---|---|
| #1 | Peptides | |
| #2 | Therapeutic chemical compounds | |
| #3 | Medical preparations | |
| #4 | Microorganisms |
| # | Name | Total Patents |
|---|---|---|
| #1 | Li Ziqiang | 14 |
| #2 | Ma Rong | 1 |
| #3 | Li Shaokui | 1 |
| #4 | Liu Yiren | 1 |
| #5 | Tian Xinsheng | 1 |
| #6 | Sun Yiping | 1 |
| Publication | Filing date | Title |
|---|---|---|
| CN111875694A | Interleukin-1 receptor antagonist and fusion protein containing same | |
| CA3106384A1 | Modified ctla4 and methods of use thereof | |
| WO2017201731A1 | Antibodies, composition and kits comprising same, and methods of use thereof | |
| CN104418951A | Application of human Nectin-2 protein |